Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects
- PMID: 34217422
- PMCID: PMC8241686
- DOI: 10.1016/j.ypmed.2021.106681
Understanding COVID-19 impact on cervical, breast, and colorectal cancer screening among federally qualified healthcare centers participating in "Back on track with screening" quality improvement projects
Abstract
The COVID-19 pandemic has contributed to decreases in breast, colorectal, and cervical cancer screenings between 86 and 94% compared to three-year averages. These postponed screenings have created backlogs that systems will need to address as healthcare facilities re-open for preventive care. The American Cancer Society is leading a 17-month intervention with 22 federally qualified health centers (FQHCs) across the United States aimed at reducing cancer incidence and mortality disparities and alleviating additional strain caused by COVID-19. This study describes COVID-related cancer screening service disruptions reported by participating FQHCs. Selected FQHCs experienced service disruptions and/or preventive care cancellations due to COVID-19 that varied in severity and duration. Fifty-nine percent stopped cancer screenings completely. Centers transitioned to telehealth visits or rescheduled for the future, but the impact of these strategies may be limited by continued pandemic-related disruptions and the inability to do most screenings at home; colon cancer screening being the exception. Most centers have resumed in-person screening, but limited in person appointments and high levels of community transmission may reduce FQHC abilities to provide catch-up services. FQHCs provide critical cancer prevention services to vulnerable populations. The delivery of culturally competent, high-quality healthcare can mitigate and potentially reverse racial and ethnic disparities in cancer prevention testing and treatment. Ensuring and expanding access to care as we move out of the pandemic will be critical to preventing excess cancer incidence and mortality in vulnerable populations.
Keywords: COVID-19; Cancer screening; FQHC.
Copyright © 2021. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Similar articles
-
Decreased Cancer Mortality-to-Incidence Ratios with Increased Accessibility of Federally Qualified Health Centers.J Community Health. 2015 Aug;40(4):633-41. doi: 10.1007/s10900-014-9978-8. J Community Health. 2015. PMID: 25634545 Free PMC article.
-
Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study.Elife. 2023 Sep 4;12:e86358. doi: 10.7554/eLife.86358. Elife. 2023. PMID: 37664989 Free PMC article.
-
National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.JAMA Intern Med. 2024 Jun 1;184(6):671-679. doi: 10.1001/jamainternmed.2024.0693. JAMA Intern Med. 2024. PMID: 38683574 Free PMC article.
-
Use of Community Health Workers and Patient Navigators to Improve Cancer Outcomes Among Patients Served by Federally Qualified Health Centers: A Systematic Literature Review.Health Equity. 2017 May 1;1(1):61-76. doi: 10.1089/heq.2017.0001. eCollection 2017. Health Equity. 2017. PMID: 28905047 Free PMC article. Review.
-
Global Impact of COVID-19 on Colorectal Cancer Screening: Current Insights and Future Directions.Medicina (Kaunas). 2022 Jan 10;58(1):100. doi: 10.3390/medicina58010100. Medicina (Kaunas). 2022. PMID: 35056408 Free PMC article. Review.
Cited by
-
A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.Prev Med. 2023 Oct;175:107649. doi: 10.1016/j.ypmed.2023.107649. Epub 2023 Jul 28. Prev Med. 2023. PMID: 37517458 Free PMC article.
-
Evaluation of a National Quality Improvement Collaborative for Improving Cancer Screening.JAMA Netw Open. 2022 Nov 1;5(11):e2242354. doi: 10.1001/jamanetworkopen.2022.42354. JAMA Netw Open. 2022. PMID: 36383381 Free PMC article.
-
Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic.Crit Rev Oncol Hematol. 2022 May;173:103656. doi: 10.1016/j.critrevonc.2022.103656. Epub 2022 Mar 23. Crit Rev Oncol Hematol. 2022. PMID: 35337970 Free PMC article.
-
Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.Int J Environ Res Public Health. 2024 Jun 21;21(7):816. doi: 10.3390/ijerph21070816. Int J Environ Res Public Health. 2024. PMID: 39063394 Free PMC article.
-
Changes in Cancer Screening in the US During the COVID-19 Pandemic.JAMA Netw Open. 2022 Jun 1;5(6):e2215490. doi: 10.1001/jamanetworkopen.2022.15490. JAMA Netw Open. 2022. PMID: 35657622 Free PMC article.
References
-
- CDC . Cdc.gov; 2020. Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19)https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html Published September 18.
-
- Epic Health Research Network . Delayed Cancer Screenings (ehrn.org); 2020. Preventive Cancer Screenings During COVID-19 Pandemic. Published May. Accessed July 1, 2020.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical